Mai Capital Management’s Abbott Laboratories Position
Does Mai Capital Management own Abbott Laboratories (ABT)? Yes — 417.8K shares worth $43M (+0.24% of its 13F portfolio) as of Q1 2026, down from 486.7K shares the prior filed quarter.
Position Value
$43M
Q1 2026
Shares
417.8K
% of Portfolio
+0.24%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 417.8K | $43M | +0.24% |
| Q4 2025 | 486.7K | $61M | +0.35% |
| Q3 2025 | 481.8K | $65M | +0.40% |
| Q2 2025 | 481.6K | $65M | +0.45% |
| Q1 2025 | 453.6K | $60M | +0.45% |
| Q4 2024 | 451.9K | $51M | +0.38% |
| Q3 2024 | 401.4K | $46M | +0.44% |
| Q2 2024 | 411.3K | $43M | +0.42% |
| Q1 2024 | 409.3K | $47M | +0.48% |
| Q4 2023 | 395.7K | $44M | +0.57% |
| Q3 2023 | 400.2K | $39M | +0.58% |
| Q2 2023 | 389.2K | $42M | +0.62% |
| Q1 2023 | 376.3K | $38M | +0.60% |
| Q4 2022 | 375.6K | $41M | +0.69% |
| Q3 2022 | 375.8K | $36M | +0.68% |
| Q2 2022 | 361.3K | $39M | +0.75% |
| Q1 2022 | 347.2K | $41M | +0.69% |
| Q4 2021 | 332.4K | $47M | +0.75% |
| Q3 2021 | 325.4K | $38M | +0.74% |
| Q2 2021 | 312.0K | $36M | +0.72% |
| Q1 2021 | 305.4K | $37M | +0.82% |
| Q4 2020 | 290.3K | $32M | +0.79% |
| Q3 2020 | 284.0K | $31M | +0.89% |
| Q2 2020 | 282.6K | $26M | +0.81% |
| Q1 2020 | 276.2K | $22M | +0.89% |
| Q4 2019 | 279.0K | $24M | +0.79% |
| Q3 2019 | 242.3K | $20M | +0.90% |
| Q2 2019 | 251.7K | $21M | +0.96% |
| Q1 2019 | 262.9K | $21M | +1.08% |
| Q4 2018 | 264.7K | $19M | +1.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mai Capital Management’s full portfolio or all institutional holders of ABT.